DICER1突变患者甲状腺病变的细胞形态学特征:7例细胞-组织病理对照报告
该研究分析7例DICER1突变患者甲状腺细针穿刺(FNA)的细胞形态学、影像及分子数据,细胞学多表现为胶质稀少、中等细胞量、均匀滤泡细胞呈小拥挤群和微滤泡,4例诊断为滤泡性肿瘤、3例诊断为意义未定的滤泡性病变,组织病理证实6/7为肿瘤性病变(3例滤泡癌、2例甲状腺乳头状癌、1例低分化癌),所有患者DICER1突变均经FNA评估发现。
要点
- DICER1突变患者甲状腺FNA常显示胶质稀少、均匀滤泡细胞小拥挤群和微滤泡。
- 细胞学诊断多为滤泡性肿瘤或意义未定的滤泡性病变,组织病理可证实为恶性。
- FNA评估在DICER1突变患者甲状腺结节筛查和监测中起关键作用。
核心结论
- DICER1突变患者甲状腺FNA细胞形态学表现为滤泡源性病变伴胶质稀少、均匀滤泡细胞小拥挤群和微滤泡。
- 所有7例患者的DICER1突变均经甲状腺FNA评估发现,强调FNA在筛查和监测中的关键作用。
研究设计与样本
- 回顾性分析7例DICER1突变患者甲状腺FNA的临床、影像、细胞形态学和分子数据。
- 细胞学诊断依据Bethesda甲状腺细胞病理学报告系统。
主要发现
- 细胞学制备显示胶质稀少、中等细胞量、均匀滤泡细胞伴圆形核和核仁不明显,呈小拥挤群和微滤泡排列。
- 细胞学诊断:4例滤泡性肿瘤,3例意义未定的滤泡性病变。
- 组织病理证实6/7例为肿瘤性病变:3例滤泡癌(FC)、2例甲状腺乳头状癌、1例低分化甲状腺癌(PDTC)。
- 遗传学检出3种不同的DICER1体细胞变异,包括c.5428G>T转录本后果,见于FC和PDTC。
关键数值与推荐
- 细胞学诊断依据Bethesda系统:4例滤泡性肿瘤,3例意义未定的滤泡性病变。
- 组织病理确诊6/7例为肿瘤性病变:3例FC、2例PTC、1例PDTC。
- 检出3种DICER1体细胞变异,包括c.5428G>T。
临床怎么用
- 对DICER1突变患者的甲状腺结节行FNA评估有助于发现甲状腺疾病及监测。
- FNA细胞形态学提示滤泡性病变时需结合组织病理和分子检测明确诊断。
局限性
- 样本量仅7例,结果需更大样本验证。
- 回顾性研究设计可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Germline and somatic mutations of DICER1 have been identified in various types of neoplastic lesions, with germline DICER1 mutation being linked to autosomal dominant hereditary pleiotropic tumor syndrome (DICER1 syndrome). Patients with DICER1 syndrome are at increased risk of developing thyroid disease, including thyroid cancer. The goal of this study was to identify diagnostic cytologic features in thyroid fine-needle aspiration (FNA) samples from patients with DICER1 mutation. METHODS: Cytology cases of thyroid FNA from 7 patients with DICER1 mutation were identified. Clinical, imaging, cytomorphologic, and molecular data were analyzed. RESULTS: Cytologic preparations from reviewed cases showed thyroid lesions of follicular derivation with scant colloid, moderate cellularity, uniform follicular cells with round nuclei and inconspicuous nucleoli arranged in small crowded groups and microfollicles. Follicular neoplasm was diagnosed in 4 cases and follicular lesion of undetermined significance in 3 cases, based on the Bethesda System for Reporting Thyroid Cytopathology. Histopathological analysis of thyroid tissue confirmed neoplastic process in 6 out of 7 cases: follicular carcinoma (FC, 3 cases), papillary thyroid carcinoma (2 cases), poorly differentiated thyroid carcinoma (PDTC, 1 case). Genetic studies identified 3 different somatic variants of DICER1 gene, including transcript consequence c.5428G>T, which was detected in FC and PDTC (and has been described previously in multinodular goiter). CONCLUSION: DICER1 mutation in all analyzed patients was identified as a result of thyroid FNA evaluation, emphasizing the critical role of FNA in the screening of patients with thyroid nodules, proper diagnosis of thyroid disease, and monitoring of patients with DICER1 mutation.
引用
- Darbinyan A, Morotti R, Cai G, et al. Cytomorphologic features of thyroid disease in patients with DICER1 mutations: A report of cytology-histopathology correlation in 7 patients. Cancer Cytopathol. 2020. PMID: 32897650. doi:10.1002/cncy.22329
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。